Author/Authors :
B. H. Anderton، نويسنده , , J. -P. Brion، نويسنده , , A-M. Couck، نويسنده , , D. R. Davis، نويسنده , , J. -M. Gallo، نويسنده , , D. P. Hanger، نويسنده , , K. Ladhani، نويسنده , , D. A. Latimer، نويسنده , , C. Lewis، نويسنده , , S. Lovestone، نويسنده , , B. Marquardt، نويسنده , , C. C. J. Miller، نويسنده , , S. F. C. Mulot، نويسنده , , C. H. Reynolds، نويسنده , , T. Rupniak، نويسنده , , C. J. Smith، نويسنده , , S. Stabel، نويسنده , , J. Woodgett، نويسنده ,
Abstract :
Two cellular systems have been used to investigate the modulation of tau hyperphosphorylation. In the first system, the effects of the excitatory amino acid glutamate, the microtubule destabilising agent colchicine, and β25–35-amyloid peptide on tau phosphorylation were studied in rat cortical neurones in primary culture. Using immunocytochemistry and western blot analysis, we demonstrated that tau in these cultures is normally highly phosphorylated, but a proportion becomes rapidly dephosphorylated following treatment of the cultures with glutamate or colchicine. These changes in tau phosphorylation occurred prior to cell death. In the second system, the ability of p42 MAP and p44 MAP kinases, glycogen synthase kinases 3a and 3β (GSK-3a and GSK-3β) to phosphorylate tau in transfected COS cells was investigated. Both GSK-3a and GSK-3β phosphorylated tau to produce a PHF-like state of phosphorylation but the MAP kinases failed to induce such a transformation in tau. These results suggest that aberrant regulation of GSK-3α/β may be a pathogenic mechanism in Alzheimerʹs disease.
Keywords :
MAP kinase , glycogen synthase kinase-3 , Alzheimerיs disease , Neurodegeneration , Primary neuronal culture , Paired helical filaments , tau , Excitatory amino acid , Colchicine , ?-amyloid , phosphorylation
